•
Dec 31, 2022

Reneo Pharmaceuticals Q4 2022 Earnings Report

EPS
-$0.55
Previous year: -$0.37
+48.6%
Cash and Equivalents
$19.9M
Previous year: $125M
-84.0%
Free Cash Flow
-$15.9M
Previous year: -$10.1M
+56.9%
Total Assets
$108M
Previous year: $154M
-29.8%

Reneo Pharmaceuticals

Reneo Pharmaceuticals